Dermovate-NN ointment

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Clobetasol propionate; Neomycin sulfate; Nystatin

Disponibil de la:

Chemidex Pharma Ltd

Codul ATC:

D07CD01

INN (nume internaţional):

Clobetasol propionate; Neomycin sulfate; Nystatin

Dozare:

500microgram/1gram ; 5mg/1gram ; 100000unit/1gram

Forma farmaceutică:

Cutaneous ointment

Calea de administrare:

Cutaneous

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 13040000

Prospect

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
DERMOVATE-NN
OINTMENT
clobetasol propionate, neomycin sulphate, nystatin
101/L/m/6b
WHAT IS IN THIS LEAFLET:
1. WHAT DERMOVATE-NN OINTMENT IS AND
WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU USE
DERMOVATE-NN OINTMENT
3. HOW TO USE DERMOVATE-NN OINTMENT
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE DERMOVATE-NN OINTMENT
6. CONTENTS OF THE PACK AND OTHER
INFORMATION 1. WHAT DERMOVATE-NN OINTMENT
IS AND WHAT IT IS USED FOR
Dermovate-NN Ointment contains clobetasol
propionate, neomycin sulphate and nystatin.

Clobetasol propionate belongs to a group
of medicines called steroids. It helps to
reduce swelling and irritation of the skin.

Neomycin sulphate and nystatin are
anti-infective medicines. They fight
bacterial and fungal infections of the skin.
Dermovate-NN Ointment is used to help
reduce the redness and itchiness of certain
skin problems. These skin problems include
eczema
or psoriasis, where an infection may
be a problem. 2. WHAT YOU NEED TO KNOW BEFORE
YOU USE DERMOVATE-NN OINTMENT
DO NOT USE DERMOVATE-NN OINTMENT:

if you are allergic to clobetasol propionate,
neomycin sulphate, nystatin or any of the
other ingredients of this medicine (listed in
section 6)

on a child under 2 years old

to treat any of the following skin problems,
it could make them worse:
- acne
- severe flushing of skin on and around
your nose (rosacea)
- spotty red rash around your mouth
(perioral dermatitis)
- itching around your b

Caracteristicilor produsului

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Dermovate-NN Ointment
Clobetasol propionate/neomycin sulphate/nystatin 0.5mg/5mg/100,000
IU/g
Ointment
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram of ointment contains clobetasol propionate 0.05% w/w,
neomycin sulphate 0.5%
w/w and nystatin 100,000 units.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Ointment.
A smooth buff coloured ointment.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Clobetasol propionate is a highly active topical corticosteroid which
is of particular
value when used in short courses for the treatment of recalcitrant
eczemas,
neurodermatoses, and other conditions which do not respond
satisfactorily to less
active steroids.
Clobetasol/neomycin/nystatin Ointment is indicated in more resistant
dermatoses
such as recalcitrant eczemas and psoriasis (excluding widespread
plaque psoriasis)
where secondary bacterial or candidal infection is present, suspected
or likely to
occur, as when using occlusive dressings.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
Adults and adolescents
Apply sparingly to the affected area once or twice daily until
improvement occurs. As with
other highly active topical steroid preparations therapy should be
discontinued when control is
achieved. In the more responsive conditions this may be within a few
days.
In very resistant lesions, especially where there is hyperkeratosis,
the anti-inflammatory
effects of Clobetasol/neomycin/nystatin Ointment can be enhanced, if
necessary, by occluding
the treatment area with polythene. Overnight occlusion only is usually
adequate to bring about
a satisfactory response, thereafter improvement can be usually
maintained by application
without occlusion.
Treatment should not be continued for more than 7 days without medical
supervision. If a
longer course is necessary, it is recommended that treatment should
not be continued for more
than 4 weeks without the patient’s condition being reviewed.
Repeat short courses of Clobet